35008
Eslicarbazepine
Cayman Chemical
DESCRIPTION
A voltage-gated sodium channel inhibitor and an active metabolite of eslicarbazepine acetate; enhances slow activation of voltage-gated sodium channels, reducing channel availability; protective against MES-induced seizures in mice (ED50 = 17.1 mg/kg)
DETAILS
- Inchi: InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1
- Purity: ≥95%
- Raptas: Product Type|Biochemicals|Ion Channel Modulation|Blockers||Research Area|Neuroscience|Seizure Disorders
- Smiles: NC(N1C2=CC=CC=C2[C@H](CC3=CC=CC=C31)O)=O
- Inchikey: BMPDWHIDQYTSHX-AWEZNQCLSA-N
- Cas Number: 104746-04-5
- Formulation: A solid
- Storage Temp: -20
- Shipping Temp: -20
- Formula Markup: C15H14N2O2
- Formula Weight: 254.3
- Shelf Life Days: 1460